Other Content - BioPharm International

ADVERTISEMENT

Other Content

Wockhardt Receives FDA Warning Letter

December 6, 2013

FDA cites cGMP violations and data-integrity issues and raises concerns over the company's ability to implement a robust and sustainable quality system.

The Impact of Biosimilars on the Innovator Market

December 4, 2013

Jill E. Sackman, D.V.M., PhD, senior consultant at Numerof & Associates, Inc. discusses the market forces impacting biopharmaceutical manufacturing

Tosoh - Monoclonal Antibody Purification with a High Capacity Protein A Resin

November 26, 2013

Tosoh - Monoclonal Antibody Purification with a High Capacity Protein A Resin

Agilent - N-Terminal Site-Specific PEGylation and Analytical-Scale Purification of PEG Lysozyme

November 22, 2013

Agilent - N-Terminal Site-Specific PEGylation and Analytical-Scale Purification of PEG Lysozyme

ProteinSimple - MFI for Particle Characterization of Biopharmaceuticals Today

November 22, 2013

ProteinSimple - MFI for Particle Characterization of Biopharmaceuticals Today

BioPharm International Author Guidelines for Supplements for 2014

November 22, 2013

BioPharm International Author Guidelines for Supplements for 2014

BioPharm International Author Guidelines for Peer-Review Papers - 2014

November 22, 2013

BioPharm International Author Guidelines for Peer-Review Papers - 2014

BioPharm International Author Guidelines for Supplements

November 20, 2013

BioPharm International Author Guidelines for Supplements

BioPharm International Peer-Review Author Guidelines

November 20, 2013

BioPharm International Peer-Review Author Guidelines

ADVERTISEMENT

ADVERTISEMENT

Click here